Effects of the BTN162b2 mRNA COVID‐19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL), the most common leukemia in the western countries, is characterized by immunosuppression due to disease itself and cytotoxic treatments. Since the beginning of COVID‐19 pandemic, patients with CLL appear to be a vulnerable population. In addition, phase III mRNA v...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorcari, Stefania, Atene, Claudio Giacinto, Maffei, Rossana, Mesini, Nicolò, Debbia, Giulia, Colasante, Corrado, Pozzi, Stefano, Barbieri, Emiliano, Maccaferri, Monica, Leonardi, Giovanna, Potenza, Leonardo, Luppi, Mario, Marasca, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537931/
https://www.ncbi.nlm.nih.gov/pubmed/36156278
http://dx.doi.org/10.1002/hon.3077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537931/
https://www.ncbi.nlm.nih.gov/pubmed/36156278
http://dx.doi.org/10.1002/hon.3077

Ejemplares similares